Form D · Pharmaceuticals
Metuchen Pharmaceuticals, LLC
Manalapan, NJ · CIK 0001799256
Offering snapshot reported Jan 9, 2020 · SEC filing
- Reported sold
- $3.13M Offering amount: $3.5M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 16, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 9, 2020 | Initial | $3,132,739 | No comparison | 30 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-357536
Source: Form D, filed Jan 9, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Greg Ford | Executive |
| Keith Lavan | Executive |
| John D. Shulman | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
200 Us Highway 9 Suite 500
Manalapan, NJ, 07726
Manalapan, NJ, 07726